Xuedong Liu Selected Research

3a.7a',7a.3a'-dihydroxyligustilide

1/2013

Antioxidant properties of cis-Z,Z'-3a.7a',7a.3a'-dihydroxyligustilide on human umbilical vein endothelial cells in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuedong Liu Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 02/2004
6	Ischemic Stroke 01/2020 - 10/2013
5	Infections 01/2021 - 04/2016
4	Ischemia 01/2020 - 12/2013
4	Stroke (Strokes) 05/2016 - 10/2013
3	Parkinson Disease (Parkinson's Disease) 08/2022 - 01/2019
3	Heart Failure 01/2022 - 01/2018
3	Inflammation (Inflammations) 01/2020 - 12/2013
3	Carcinogenesis 01/2016 - 09/2005
2	Neuroinflammatory Diseases 08/2022 - 01/2020
2	COVID-19 06/2022 - 05/2022
2	Leukocytosis (Pleocytosis) 01/2022 - 03/2010
2	Pleural Effusion (Pleural Effusions) 01/2022 - 09/2020
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2020
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2019
2	Brain Ischemia (Cerebral Ischemia) 01/2020 - 12/2013
2	Lymphoma (Lymphomas) 01/2019 - 01/2017
2	Liver Neoplasms (Liver Cancer) 07/2018 - 01/2017
2	Wounds and Injuries (Trauma) 01/2016 - 01/2013
2	Memory Disorders (Memory Loss) 07/2014 - 08/2012
1	Neuroblastoma 10/2022
1	Sarcoidosis (Schaumann Disease) 06/2022
1	Fever (Fevers) 05/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022
1	Hyponatremia 01/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022
1	Azotemia 01/2022
1	Tuberous Sclerosis (Bourneville's Disease) 12/2021
1	Angiofibroma 12/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021
1	Healthcare-Associated Pneumonia 09/2020
1	Brain Edema (Cerebral Edema) 01/2020
1	Asthma (Bronchial Asthma) 09/2019
1	Sepsis (Septicemia) 01/2019
1	Confusion (Bewilderment) 01/2019
1	Human Influenza (Influenza) 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Lung Neoplasms (Lung Cancer) 07/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017
1	Leukemia 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 06/2022 - 09/2004
7	Transforming Growth Factor beta (TGF-beta)IBA 05/2009 - 02/2004
5	ginsenoside RdIBA 01/2020 - 12/2013
4	UbiquitinIBA 01/2021 - 09/2004
3	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2018
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 09/2004
2	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2022
2	Urea (Carbamide)FDA LinkGeneric 01/2022 - 01/2019
2	SodiumIBA 01/2022 - 09/2020
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2022 - 01/2019
2	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2018
2	Neuroprotective AgentsIBA 01/2020 - 12/2013
2	Oxygen (Dioxygen)IBA 01/2020 - 01/2019
2	Phosphotransferases (Kinase)IBA 08/2014 - 01/2012
1	AMP-Activated Protein KinasesIBA 10/2022
1	CalciumIBA 10/2022
1	EndocannabinoidsIBA 08/2022
1	Nucleic AcidsIBA 05/2022
1	TriterpenesIBA 01/2022
1	NitrogenIBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	GlucocorticoidsIBA 01/2022
1	AcidsIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	bardoxoloneIBA 01/2022
1	trans-sodium crocetinate (crocetin)IBA 12/2021
1	BerberineIBA 11/2021
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2021
1	Indoleacetic Acids (Auxin)IBA 01/2021
1	benzophenoneIBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	ProdrugsIBA 01/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020
1	protopanaxadiolIBA 01/2020
1	N-Methylaspartate (NMDA)IBA 01/2020
1	Evans Blue (Blue, Evans)FDA Link 01/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020
1	CalcineurinIBA 01/2020
1	parkin proteinIBA 01/2019
1	MEF2 Transcription FactorsIBA 07/2018
1	MicroRNAs (MicroRNA)IBA 07/2018
1	LactamsIBA 01/2018
1	Cyclin D1IBA 01/2018
1	AlbuminsIBA 01/2018
1	FluoroquinolonesIBA 01/2018
1	MethyltransferasesIBA 01/2017
1	Non-Receptor Type 6 Protein Tyrosine PhosphataseIBA 01/2017
1	Protein Kinases (Protein Kinase)IBA 01/2017
1	Sorafenib (BAY 43-9006)FDA Link 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Peptides (Polypeptides)IBA 05/2016
1	Therapeutic UsesIBA 05/2016

Therapy/Procedure

7	Therapeutics 05/2022 - 06/2011
1	Transcranial Magnetic Stimulation 08/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Bronchial Thermoplasty 09/2019
1	Radiofrequency Ablation 09/2019